Chartwell Investment Partners’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $761K | Hold |
11,356
| – | – | 0.03% | 372 |
|
|
2024
Q2 | $1.29M | Buy |
11,356
+1,653
| +17% | +$187K | 0.05% | 321 |
|
|
2024
Q1 | $1.35M | Buy |
9,703
+3,513
| +57% | +$487K | 0.05% | 334 |
|
|
2023
Q4 | $768K | Sell |
6,190
-5,900
| -49% | -$732K | 0.03% | 381 |
|
|
2023
Q3 | $1.13M | Sell |
12,090
-18,317
| -60% | -$1.71M | 0.04% | 344 |
|
|
2023
Q2 | $3.91M | Buy |
30,407
+5,553
| +22% | +$714K | 0.14% | 224 |
|
|
2023
Q1 | $2.89M | Buy |
24,854
+37
| +0.1% | +$4.3K | 0.11% | 243 |
|
|
2022
Q4 | $2.81M | Sell |
24,817
-40
| -0.2% | -$4.53K | 0.11% | 238 |
|
|
2022
Q3 | $2M | Buy |
24,857
+20,006
| +412% | +$1.61M | 0.09% | 267 |
|
|
2022
Q2 | $361K | Buy |
4,851
+19
| +0.4% | +$1.41K | 0.01% | 405 |
|
|
2022
Q1 | $618K | Hold |
4,832
| – | – | 0.02% | 398 |
|
|
2021
Q4 | $649K | Hold |
4,832
| – | – | 0.02% | 402 |
|
|
2021
Q3 | $660K | Hold |
4,832
| – | – | 0.02% | 401 |
|
|
2021
Q2 | $516K | Hold |
4,832
| – | – | 0.02% | 409 |
|
|
2021
Q1 | $434K | Hold |
4,832
| – | – | 0.01% | 404 |
|
|
2020
Q4 | $447K | Hold |
4,832
| – | – | 0.01% | 408 |
|
|
2020
Q3 | $498K | Buy |
4,832
+256
| +6% | +$26.4K | 0.02% | 394 |
|
|
2020
Q2 | $464K | Buy |
4,576
+204
| +5% | +$20.7K | 0.02% | 380 |
|
|
2020
Q1 | $294K | Hold |
4,372
| – | – | 0.01% | 381 |
|
|
2019
Q4 | $239K | Buy |
+4,372
| New | +$239K | 0.01% | 403 |
|